Please use this identifier to cite or link to this item:
https://doi.org/10.21256/zhaw-28185
Publication type: | Article in scientific journal |
Type of review: | Peer review (publication) |
Title: | Incidence and costs of hypoglycemia in insulin-treated diabetes in Switzerland : a health-economic analysis |
Authors: | Tzogiou, Christina Wieser, Simon Eichler, Klaus Carlander, Maria Djalali, Sima Rosemann, Thomas Brändle, Michael |
et. al: | No |
DOI: | 10.1016/j.jdiacomp.2023.108476 10.21256/zhaw-28185 |
Published in: | Journal of Diabetes and its Complications |
Volume(Issue): | 37 |
Issue: | 6 |
Page(s): | 108476 |
Issue Date: | Jun-2023 |
Publisher / Ed. Institution: | Elsevier |
ISSN: | 1056-8727 1873-460X |
Language: | English |
Subjects: | Diabetes mellitus; Hypoglycemia; Insulin; Medical cost; Production loss; Switzerland |
Subject (DDC): | 362.1041: Health economics |
Abstract: | Aims: We assess the incidence and economic burden of severe and non-severe hypoglycemia in insulin-treated diabetes type 1 and 2 patients in Switzerland. Methods: We developed a health economic model to assess the incidence of hypoglycemia, the subsequent medical costs, and the production losses in insulin-treated diabetes patients. The model distinguishes between severity of hypoglycemia, type of diabetes, and type of medical care. We used survey data, health statistics, and health care utilization data extracted from primary studies. Results: The number of hypoglycemic events in 2017 was estimated at 1.3 million in type 1 diabetes patients and at 0.7 million in insulin-treated type 2 diabetes patients. The subsequent medical costs amount to 38 million Swiss Francs (CHF), 61 % of which occur in type 2 diabetes. Outpatient visits dominate costs in both types of diabetes. Total production losses due to hypoglycemia amount to CHF 11 million. Almost 80 % of medical costs and 39 % of production losses are due to non-severe hypoglycemia. Conclusions: Hypoglycemia leads to substantial socio-economic burden in Switzerland. Greater attention to non-severe hypoglycemic events and to severe hypoglycemia in type 2 diabetes could have a major impact on reducing this burden. |
URI: | https://digitalcollection.zhaw.ch/handle/11475/28185 |
Fulltext version: | Published version |
License (according to publishing contract): | CC BY 4.0: Attribution 4.0 International |
Departement: | School of Management and Law |
Organisational Unit: | Winterthur Institute of Health Economics (WIG) |
Appears in collections: | Publikationen School of Management and Law |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
2023_Tzogiou-etal_Incidence-and-cost-of-hypoglycemia-insulin-treated-diabetes-CH.pdf | 3.51 MB | Adobe PDF | View/Open |
Show full item record
Tzogiou, C., Wieser, S., Eichler, K., Carlander, M., Djalali, S., Rosemann, T., & Brändle, M. (2023). Incidence and costs of hypoglycemia in insulin-treated diabetes in Switzerland : a health-economic analysis. Journal of Diabetes and Its Complications, 37(6), 108476. https://doi.org/10.1016/j.jdiacomp.2023.108476
Tzogiou, C. et al. (2023) ‘Incidence and costs of hypoglycemia in insulin-treated diabetes in Switzerland : a health-economic analysis’, Journal of Diabetes and its Complications, 37(6), p. 108476. Available at: https://doi.org/10.1016/j.jdiacomp.2023.108476.
C. Tzogiou et al., “Incidence and costs of hypoglycemia in insulin-treated diabetes in Switzerland : a health-economic analysis,” Journal of Diabetes and its Complications, vol. 37, no. 6, p. 108476, Jun. 2023, doi: 10.1016/j.jdiacomp.2023.108476.
TZOGIOU, Christina, Simon WIESER, Klaus EICHLER, Maria CARLANDER, Sima DJALALI, Thomas ROSEMANN und Michael BRÄNDLE, 2023. Incidence and costs of hypoglycemia in insulin-treated diabetes in Switzerland : a health-economic analysis. Journal of Diabetes and its Complications. Juni 2023. Bd. 37, Nr. 6, S. 108476. DOI 10.1016/j.jdiacomp.2023.108476
Tzogiou, Christina, Simon Wieser, Klaus Eichler, Maria Carlander, Sima Djalali, Thomas Rosemann, and Michael Brändle. 2023. “Incidence and Costs of Hypoglycemia in Insulin-Treated Diabetes in Switzerland : A Health-Economic Analysis.” Journal of Diabetes and Its Complications 37 (6): 108476. https://doi.org/10.1016/j.jdiacomp.2023.108476.
Tzogiou, Christina, et al. “Incidence and Costs of Hypoglycemia in Insulin-Treated Diabetes in Switzerland : A Health-Economic Analysis.” Journal of Diabetes and Its Complications, vol. 37, no. 6, June 2023, p. 108476, https://doi.org/10.1016/j.jdiacomp.2023.108476.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.